title: A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.
abstract: The blood-brain barrier (BBB) restricts the delivery of drugs into the brain. Different strategies have been developed to circumvent this obstacle. One such approach, the osmotic BBB disruption (BBBD), has been under pre-clinical study since the 70's. Typically, qualitative ex vivo assessment of the extent of BBBD has been performed using Evan's blue staining technique. In this study, we describe a simple quantitative technique based on albumin indirect immunohistochemistry to measure the extent of BBB breach. Thirty Fischer rats were assigned to one of 6 groups: a control group, and BBBD groups with escalation in IA mannitol infusion rate: 0.06, 0.08, 0.10, 0.12 and 0.15 cc/s. Fifteen minutes after the BBBD procedure, the animals were sacrificed, brain harvested and sections stained for albumin. Using an image analysis software, isolated albumin staining pixels were expressed as a fraction of the treated hemisphere. This ratio was used as a percentage value in the intensity of the BBB permeabilization. All sections studied harbored staining, averaging 0.37% for the controls (group 1), 5.69% for group 2 (0.06 cc/s), 10.44% for group 3 (0.08 cc/s), 6.99% for group 4 (0.1 cc/s), 18.50% for group 5 (0.12 cc/s) and reaching 61.70% for group 6 (0.15 cc/s). Important variations were observed between animals. A threshold effect was observed, and animals in group 6 presented a significant increase in BBB permeabilization compared to the other groups. We hereby detail a simple technique that can be applied to quantitatively measure the extent of the BBB breach notwithstanding the pathological process.
authors.affiliation: Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Canada.
authors.forename: Marie
authors.initials: M
authors.lastname: Blanchette
authors.forename: Karine
authors.initials: K
authors.lastname: Michaud
authors.forename: David
authors.initials: D
authors.lastname: Fortin
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D004234:Diuretics, Osmotic / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D005070:Evans Blue / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D007260:Infusion Pumps; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics; D023421:Models, Animal; D011897:Random Allocation; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D004234:Diuretics, Osmotic; D008353:Mannitol; D005070:Evans Blue